Follow-up imaging after liver transplantation should take into consideration primary hepatocellular carcinoma characteristics

Transplantation

Volumn 99, Issue 8, 2015, Pages 1613-1618

  Burgio, Marco Dioguardi ^a,d   Ronot, Maxime ^a,b,c,e   Fuks, David ^a,b   Dondero, Federica ^a   Cauchy, François ^a   Gaujoux, Sébastien ^a,b   Dokmak, Safi ^a   Paradis, Valérie ^a,b,c   Durand, François ^a,b   Belghiti, Jacques ^a,b   Vilgrain, Valérie ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^d UNIVERSITY OF PALERMO   (Italy)

^e BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL WALL; ADULT; ARTICLE; BONE; CANCER RECURRENCE; CANCER STAGING; ECHOGRAPHY; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; HEPATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERITONEUM; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SPLEEN; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME; UNIVERSITY HOSPITAL; WHOLE BODY IMAGING; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84942474016     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000659     Document Type: Article

References (30)

1. Mazzaferro V, Bhoori S, Sposito C, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011;17(Suppl 2):S44-S57.
2. Zimmerman MA, Ghobrial RM, Tong MJ, et al. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg. 2008;143(2):182-188; discussion 188.
3. Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004;10(4):534-540.
4. Dumitra TC, Dumitra S, Metrakos PP, et al. Pretransplantation alphafetoprotein slope and Milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation. Transplantation. 2013;95(1): 228-233.
5. Grasso A, Stigliano R, Morisco F, et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation. 2006;81(11):1532-1541.
6. Kotlyar DS, Campbell MS, Reddy KR. Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol. 2006;101(6):1370-1378.
7. Lao OB, Weissman J, Perkins JD. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Clin Transplant. 2009;23(6):874-881.
8. Marelli L, Grasso A, Pleguezuelo M, et al. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score. Ann Surg Oncol. 2008; 15(12):3503-3511.
9. Welker MW, Bechstein WO, Zeuzem S, Trojan J. Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge. Transpl Int. 2012;26(2):109-118.
10. Yoshizumi T, Ikegami T, Yoshiya S, et al. Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma. Hepatol Res. 2012;43(7):709-716.
11. De Carlis L, Di Sandro S, Giacomoni A, et al. Beyond the Milan criteria: what risks for patients with hepatocellular carcinoma progression before liver transplantation? J Clin Gastroenterol. 2012;46(1):78-86.
12. Hwang S, Kim YH, Kim DK, et al. Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation. World J Surg. 2012;36(7):1592-1602.
13. Pfiffer TE, Seehofer D, Nicolaou A, Neuhaus R, Riess H, Trappe RU. Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era. Tumori. 2011;97(4):436-441.
14. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13(1):e11-e22.
15. Ferris JV, Baron RL, Marsh JWJr, Oliver JH 3rd, Carr BI, Dodd GD 3rd. Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology. 1996;198(1):233-238.
16. Lee CH, Brubaker LM, Gerber DA, et al. MRI findings of recurrent hepatocellular carcinoma after liver transplantation: preliminary results. J Magn Reson Imaging. 2011;33(6):1399-1405.
17. Castroagudin JF, Molina-Perez E, Ferreiro-Iglesias R, et al. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed? Transplant Proc. 2012;44(6):1565-1567.
18. Chok KS, Chan SC, Cheung TT, Chan AC, Fan ST, Lo CM. Late recurrence of hepatocellular carcinoma after liver transplantation. World J Surg. 2011;35(9):2058-2062.
19. Toso C, Cader S, Mentha-Dugerdil A, et al. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence. J Hepatobiliary Pancreat Sci. 2013;20(3):342-347.
20. Regalia E, Fassati LR, Valente U, et al. Pattern andmanagement of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg. 1998;5(1):29-34.
21. Davis E, Wiesner R, Valdecasas J, Kita Y, Rossi M, Schwartz M. Treatment of recurrent hepatocellular carcinoma after liver transplantation. Liver Transpl. 2011;17(Suppl 2):S162-S166.
22. Lee DH, Lee JM, Lee JY, et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270(3):900-909.
23. Tohme S, Geller DA, Cardinal JS, et al. Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. HPB (Oxford). 2012;15(3):210-217.
24. Cescon M, Ravaioli M, Grazi GL, et al. Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. J Transplant. 2010;2010.
25. Escartin A, Sapisochin G, Bilbao I, et al. Recurrence of hepatocellular carcinoma after liver transplantation. Transplant Proc. 2007;39(7): 2308-2310.
26. Sharma P, Welch K, Hussain H, et al. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era. Dig Dis Sci. 2012;57(3):806-812.
27. Valdivieso A, Bustamante J, Gastaca M, et al. Management of hepatocellular carcinoma recurrence after liver transplantation. Transplant Proc. 2010;42(2):660-662.
28. Roberts JP. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation. Liver Transpl. 2005;(11 Suppl 2):S45-S46.
29. Hatzaras I, Bischof DA, Fahy B, Cosgrove D, Pawlik TM. Treatment options and surveillance strategies after therapy for hepatocellular carcinoma. Ann Surg Oncol. 2014;21:758-766.
30. Schlitt HJ, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol. 1999;17(1):324-331.